Skip to main content
. 2016 Oct 25;28(2):278–284. doi: 10.1093/annonc/mdw556

Table 2.

Study drug-related adverse events seen in ≥10% of patients

CTCAE term Grade 1 Grade 2 Grade 3 Grade 4 Total (any grade)
Rash 21 (62%) 8 (24%) 1 (3%) 0 30 (88%)
Diarrhea 24 (71%) 1 (3%) 4 (12%) 0 29 (85%)
Nausea 10 (29%) 3 (9%) 2 (6%) 0 15 (44%)
Fatigue 8 (24%) 4 (12%) 0 0 12 (35%)
Mucositis 8 (24%) 3 (9%) 1 (3%) 0 12 (35%)
Pruritis 11 (32%) 0 0 0 11 (32%)
Vomiting 9 (26%) 1 (3%) 1 (3%) 0 11 (32%)
Bilirubin increased 4 (12%) 5 (15%) 2 (6%) 0 11 (32%)
Dry skin 10 (29%) 0 0 0 10 (29%)
ALT elevated 6 (18%) 1 (3%) 1 (3%) 0 8 (24%)
Alopecia 7 (21%) 0 0 0 7 (21%)
AST increased 5 (15%) 1 (3%) 0 0 6 (18%)
Paronychia 4 (12%) 2 (6%) 0 0 6 (18%)
Anorexia 3 (9%) 2 (6%) 0 0 5 (15%)
Anemia 2 (6%) 1 (3%) 1 (3%) 0 4 (12%)